Evidence map›Paper›PMID 33374283›Full record

ArticleNutrients2020

Mexican

Sandra L Romero-Córdoba, Ivan Salido-Guadarrama, María E Meneses, Giulia Cosentino, Marilena V Iorio, Elda Tagliabue, Nimbe Torres, Mónica Sánchez-Tapia, Myrna Bonilla, Ivan Castillo and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Natural Products in Renal-Associated Drug Discovery.Antioxidants (Basel, Switzerland) · 2023
    Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Sandra L Romero-CórdobaBiochemistry Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMNSZ), Mexico City 14080, Mexico.ORCID 0000-0002-5591-696X
Ivan Salido-GuadarramaLaboratorio de Biología Computacional, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas (INER), Mexico City 14080, Mexico.
María E MenesesCentre of Biotechnology of Medicinal, Functional, and Edible Mushrooms, Colegio de Postgraduados (CP), Campus Puebla, Boulevard Forjadores de Puebla no. 205, Puebla 72760, Mexico.ORCID 0000-0002-7689-7024
Giulia CosentinoMolecular Targeting Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.ORCID 0000-0001-9223-0943
Marilena V IorioMolecular Targeting Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Elda TagliabueMolecular Targeting Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.ORCID 0000-0001-9877-2903
Nimbe TorresDepartamento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMNSZ), Mexico City 14080, Mexico.ORCID 0000-0002-1741-0984
Mónica Sánchez-TapiaDepartamento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMNSZ), Mexico City 14080, Mexico.
Myrna BonillaCentre of Biotechnology of Medicinal, Functional, and Edible Mushrooms, Colegio de Postgraduados (CP), Campus Puebla, Boulevard Forjadores de Puebla no. 205, Puebla 72760, Mexico.
Ivan CastilloCentre of Biotechnology of Medicinal, Functional, and Edible Mushrooms, Colegio de Postgraduados (CP), Campus Puebla, Boulevard Forjadores de Puebla no. 205, Puebla 72760, Mexico.
Beatriz PetlacalcoCentre of Biotechnology of Medicinal, Functional, and Edible Mushrooms, Colegio de Postgraduados (CP), Campus Puebla, Boulevard Forjadores de Puebla no. 205, Puebla 72760, Mexico.
Armando R TovarDepartamento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMNSZ), Mexico City 14080, Mexico.
Daniel Martínez-CarreraCentre of Biotechnology of Medicinal, Functional, and Edible Mushrooms, Colegio de Postgraduados (CP), Campus Puebla, Boulevard Forjadores de Puebla no. 205, Puebla 72760, Mexico.ORCID 0000-0003-3878-1802
Colegio de Postgraduados · MXInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXFondazione IRCCS Istituto Nazionale dei Tumori · ITInstituto Nacional de Enfermedades Respiratorias · MX

Funding

Consejo Nacional de Ciencia y Tecnología Cátedras 105Consejo Nacional de Ciencia y Tecnología FORDECYT-273647
6 · The paper itself

Abstract

Prevention of hyperlipidemia and associated diseases is a health priority. Natural products, such as the medicinal mushroom

Indexed as

AnimalsAnticholesteremic AgentsCholesterol, DietaryGastrointestinal MicrobiomeKidneyLipid MetabolismLipogenesisLiverMaleMetabolic Networks and PathwaysMiceMice, Inbred C57BLPrebioticsRAW 264.7 CellsReishiTranscriptomeAnticholesteremic AgentsCholesterol, DietaryPrebioticsGanoderma lucidumhypercholesterolemialipid catabolismmicrobiotatranscriptional profiles

Identifiers

PMID33374283
PMCPMC7823885
OpenAlexW3116303244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.